Despite high hopes for early cryoprecipitate intervention, the CRYOSTAT-2 study reveals it doesn t significantly enhance outcomes in patients with trauma.
This clinical trial examines whether early, empirical, high-dose cryoprecipitate, in addition to standard major hemorrhage protocols, would improve survival in
Not all major trauma patients benefit from receiving additional blood-clotting factors when treating blood loss: Study medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.